首页 研究 调查 数据 调研 战略 供需 策略 专项 现状 风险 运营 监测 深度 竞争 发展 专题 评估 动态 规划 咨询 投资 市场 分析 前景 预测 原创 行业 盈利 评价 经营 规模 观点 展望 前瞻 效益 服务 企业 渠道 细分 区域 投机 企业 生产 趋势 格局 销售 技术 状况 经销 环境 财务 风投 供应 产品 产销 商机 项目 能力 新闻
报告检索
您当前的位置:首页 > 战略报告 > 正文

Market survey report on Chinas pharmaceutical e-commerce industry in 2018-2025 years

Market survey report on Chinas pharmaceutical e-commerce industry in 2018-2025 years

郑重声明

特别声明:以下报告是由亚泰中研公司权威发布,尽可放心购买。

(北京亚泰中研咨询公司):我公司对所有研究报告产品拥有唯一著作权,公司从未通过任何第三方进行代理销售。亚泰中研是中国拥有研究人员数量最多、规模最大、实力最强的咨询研究机构,报告目录与内容未经亚泰中研公司事先书面许可,拒绝任何方式复制、转载。

  本文章共12702字,分2页,当前第1页,快速翻页:12(the following report is coded B017472, issued by the authority of Yatai China Research Corporation.
[text - version]: the price is 6500 yuan (text version).
[electricity sub edition]: the price is 6800 yuan (electronic version).
[Wen Dian = edition]: the price is 7500 yuan (full version).
[writing unit] Beijing Yatai China Research Corporation
The price is 6000 USD.
[publication date]: the latest authoritative publication.
[report]: text analysis data comparison chart
[delivery time]: within 1 working days
[delivery mode: express mail / SF express /
[link] - Liu Yang / Zhang Ke / Liu Dan
[subscribe phone]: 010-57302159 / 13051511061
[Green Channel]: 13051511061 / 15600031156
[report website]: http://www.yzyjbg.net http://www.zgcysddy.com/
[report name]: 2018-2025 years of forward-looking report on Chinas pharmaceutical e-commerce market
Key words: pharmaceutical e-commerce
[report directory]
The first part is the overview of e-commerce related medicine 25
Chapter 1 Analysis of Chinas pharmaceutical industrys overall operation form 25
Section 1 general situation of Chinas pharmaceutical industry development 25
First, the development course of Chinas pharmaceutical industry in the past thirty years of reform and opening up 25
Two, Chinas pharmaceutical industry is in a critical period of adjustment and upgrading 28
Three, the development of Chinese pharmaceutical market in multinational pharmaceutical enterprises 29
Four. The regulatory role of the government in the transition period of Chinas pharmaceutical industry 33
Five. Analysis of the current situation of the combination of Chinese and Western medicines 39
The second section summarizes the current situation of Chinas pharmaceutical industry 42
1. Pharmaceutical enterprises 42
Two. The increase of patients medical expenses in Chinas medical market is reduced by 45.
The third section analyzes the main foreign trade market of Chinese medicine products 46
Analysis of China and Indias pharmaceutical trade market 46
Two. Analysis of Sino German medicine trade 46
Three. Analysis of Sino British medicine trade 48
Four. Analysis of Sino French trade in medicine 49
Five. Analysis of Sino Russian medicine trade situation 50
The second chapter analyzes the development of Chinese medicine circulation field 53
Section 1 overview of drug circulation in China 53
1. Particularity of drug circulation process 53
Two, profit distribution in drug circulation link chain 54
Three. Successful experience in drug circulation abroad. 59
The second section, the development of Chinese medicine circulation field 61
1. The development of Chinas pharmaceutical circulation industry has achieved remarkable results 61
Two. Analysis of the reform and development of pharmaceutical circulation in China 62
Three, Chinas pharmaceutical circulation industry is still in its initial stage of development 66
Four, Chinas pharmaceutical circulation industry goes ahead in the regulation 68
Five, the pharmaceutical circulation industry will ce the impact of the new deal 68
Six, the pharmaceutical circulation industry 13th Five-Year development plan will be released 70
Seven, the three development trends of Chinas pharmaceutical circulation industry in the future 71
The third section analysis of the pattern of Chinese medicine circulation industry 73
First, the analysis of the pattern change of Chinas pharmaceutical circulation industry 73
Two, the new direction of medical reform will affect the development of Chinas pharmaceutical circulation industry 73
Three, the rise of regional alliance, pharmaceutical circulation industry competition intensified 74
Four, analysis of the development trend of Chinas pharmaceutical circulation market 76
The fourth section analysis of Chinese pharmaceutical circulation enterprises in the past three years 80
1. The growth of Chinese pharmaceutical circulation industry is better than that of the enterprise analysis 80
Analysis of the development of top 100 pharmaceutical circulation enterprises in China in two and 2016 80
Three. Analysis of the development of top 100 pharmaceutical circulation enterprises in China 82
The fifth section of drug circulation industry warehouse management analysis 82
I. challenges ced by Chinas pharmaceutical circulation industry in warehousing management 82
Two, Chinas pharmaceutical circulation industry storage management measures 84
The sixth section challenges and Countermeasures for the development of Chinese medicine circulation field 87
1. The main problems existing in the pharmaceutical circulation industry 87
Two, Chinas pharmaceutical distribution industry is cing internal and external troubles 88
Three, the pharmaceutical circulation industry needs to be large-scale and centralized 89.
Four, the problems and improvement measures of Chinas medicine circulation logistics supply chain 91
Five, development strategy of pharmaceutical circulation 92
Six, pharmaceutical circulation enterprises should prepare for the rainy day 93
The third chapter analyzes the subdivision of Chinas pharmaceutical circulation 96
Section 1 wholesale of medicine 96
First, pharmaceutical wholesalers are the key link of circulation channels 96
Two, the three market levels of Chinese pharmaceutical wholesale enterprises 97
Three, China pharmaceutical wholesale enterprise chain operation development situation analysis 98
Four, the impact of the new medical reform policy on the development of small and medium-sized pharmaceutical wholesale enterprises 99
Five, strategic transformation of pharmaceutical wholesalers 101
Six. Analysis of the development of drug wholesale enterprises at the grass-roots level 101
Seven, the development status of Chinas pharmaceutical business wholesale alliance 102
Eight, Chinas pharmaceutical wholesale industry development countermeasures and suggestions 105
The second section of Medicine Agency 106
Four stages of the development of Chinas pharmaceutical agency system 106
Two. Regional distribution of Chinese pharmaceutical agents is not equal to 107
Three, Chinas pharmaceutical agents enter the meager profit era 108
Four, the policy situation ced by pharmaceutical agents and its way out analysis 109
Five. Discussion and strategy analysis of hot issues in Chinas pharmaceutical agency industry 110
Third medicine retail 114
Development of Chinas pharmaceutical retail industry 114
Two, the domestic drug retail market is developing rapidly 114
Three. Analysis of the development of Chinas pharmaceutical retail market in the past three years 115
Four, Chinas pharmaceutical retail market has great potential for development 117
Five, pharmaceutical retail business market innovation and development 118
Six. Analysis of the pharmaceutical retail industry under the new healthcare reform 120
Seven, retail chain pharmacies business mode to accelerate transformation 121
The second part is the analysis of the operation environment of pharmaceutical e-commerce. 123
The fourth chapter is about the overview of medical electronic commerce 123
Section 1 overview of e-commerce in the pharmaceutical industry 123
First, the electronic business of the pharmaceutical industry.The seventh chapter analyzes the operation environment of Chinese pharmaceutical e-commerce industry 139
Section 1 policy analysis of online pharmacies 139
I. The content and effect of Chinas online pharmacies policy 139
Two. The existing management laws and problems of Chinese online pharmacies 140
Three. Preliminary exploration of drug electronic commerce regulation 141
Four, Internet drug information service management measures 142
Five. Interim Provisions on the examination and approval of Internet drug transaction services 149
The second section analyzes the operation of Internet pharmacies economic environment 158
I. national economic operation P (quarterly update) 158
Two, consumer price index CPI, PPI (updated monthly) 159
Three, the national income of residents (quarterly update) 162
Four, Engel coefficient (annual update) 164
Five, industrial development situation (quarterly update) 164
Six, fixed asset investment (quarterly update) 166
Seven, total retail sales of consumer goods 168
Eight. Foreign Trade & import and export 170
The third section of online pharmacy operation social environment analysis 173
First, Chinas online shopping is rapidly popularizing to the public 173
Two, Chinese netizens are touting online shopping 175 under the financial crisis.
Three, online shopping ranks among the ten largest Internet applications listed in 177.
Four, local norms open online shopping to follow the door 177
The fourth section of online pharmacy operation technology environment analysis 178
1. Chinas Internet development situation 178
Two, online transaction security analysis 188
The fifth section of the online pharmacies market macro situation 189
1. Penetration rate of online shopping 189
Two, shopping amount 190
Three. The penetration rate of shopping websites is 190
Four, shopping website user market share 191
Five, shopping website user coincidence degree 193
The eighth chapter analyzes the market operation situation of Chinese pharmaceutical e-commerce industry 194
Section 1 operation status of Chinas pharmaceutical e-commerce industry 194
First, the development of Chinese medicine e-commerce is still in its initial stage 194
Two, the advent of the era of large-scale pharmaceutical electronic commerce 194
Three. Value chain development and utilization of pharmaceutical e-commerce 195
The second section of Chinese medicine e-commerce website system planning and construction 196
First, the composition of the medical e-commerce website system 196
Two, strategic planning of the pharmaceutical e-commerce website system 197
Three, analysis and design of medical e-commerce website system 198
Four. Management of medical e-commerce website system 198
The third section analyzes the market dynamics of Chinese medicine websites 199
First, the medical website is in high spirits 199
Two, the opening of medical and health websites is 199
Three. Typical enterprise analysis 199
The fourth section discusses the hot topics of Chinese medicine e-commerce market 201
First, the development level of Chinas pharmaceutical e-commerce is low 201
Two, the regulatory means and level of supervision can not keep up with Internet technology and market demand 201
Three, the degree of marketization of pharmaceutical e-commerce is not high 201
Four, the distribution of logistics networks across the country is 202.
The ninth chapter: Chinese medicine electronic commerce industry -- B2B mode analysis 203
Section 1: analysis of China pharmaceutical e-commerce B2B mode industry chain 203
I. medical institutions 203
Two, pharmaceutical wholesale enterprises 203
Three, bank 204
Four, pharmaceutical manucturers 205
Five, medical information service provider 205
Six, insurance company 205
The second section, the development of B2B mode of Chinas pharmaceutical e-business 206
1. The main characteristics of Chinese medicine e-commerce 206
Two. BtoB mode medical electronic transactions are mainly implemented in the centralized bidding procurement of pharmaceuticals 207.
The third section of Chinese medicine e-commerce -- B2B mode in-depth dialysis 208
I. enterprise informatization mode 208
Two, industry alliance exchange mode 208
Three, leap forward third party electronic trading market mode 209
The fourth section of future development strategy and countermeasure 209
First, the independent third party electronic market is in line with Chinas situation 209
Two. Market environment and system construction for pharmaceutical e-commerce. 210
Three, cultivate third party logistics 211
Four, integrate existing resources to build third party electronic trading network covering the whole country 212
The tenth chapter analyzes the market operation situation of Chinas online pharmacies 213
Section 1 dynamic analysis of the operation of Chinese online pharmacies 213
First, third online pharmacies in Shanghai opened 213
Two. Tongrentang plans to open a shop online to sell medicine 213
Three. The first online drug in the west is 214.
Four. The impact of social security cards on online pharmacies 214
The second section summarizes the operation of Chinese online pharmacies 215
1. The development stage of Chinese online pharmacies is 215
Two, Chinas online pharmacies speed up 216
Three, comparison of the development regulation of online pharmacies at home and abroad 217
Four. Experience from Chinese online pharmacies (Germany) 217
Five, online pharmacies development ideas - specific solutions 218
Six, electronic commerce card overturns traditional pharmacies mode 222
Seven, online pharmacies money scene may no longer be virtual 223
The third quarter of Chinas online pharmacies consumer group analysis 224
1. Analysis of consumer characteristics of online pharmacies 224
Two, online pharmacies consumer demand area analysis 225
Three, online pharmacy consumer consumption capacity analysis 225
The fourth quarter online pharmacy supply analysis 226
Analysis of the number of online pharmacies 226
Two, the scale of online pharmacies in China is 226
Three. Analysis of the regional characteristics of online pharmacies 226
Four, online pharmacy supply characteristics analysis 227
The fifth section of Chinas online pharmacies market problems 227
I. illegal operation is generally 227
Two, consumer trust is less than 228.
Three, online pharmacies sell into global problems 228
Four, online pharmacies regulatory issues 229
Five, analysis of the problems restricting the development of online drugstores in China 230
The sixth quarter analysis of Chinas online pharmacy development strategy 231
First, increase the management of online pharmacies 231
Two, increase the publicity of online pharmacies 231
Three, improve the service level of online pharmacies 232
Four, do a good job of online pharmacies level of technology 232
The eleventh chapter analyzes the development and sales forecast of Chinas pharmaceutical e-business 233
Section 1 competition of Chinas pharmaceutical e-commerce industryFive. Shenzhen Tianchi Medical Information Technology Development Co., Ltd. 268
(1) analysis of debt paying ability of enterprises 268
(two) enterprise operation capability analysis 270
(three) profitability analysis of enterprises 274
The second quarter B2C business mode four four
Beijing Jinxiang pharmacy pharmacy chain Co., Ltd. 275
(1) analysis of debt paying ability of enterprises 276
(two) enterprise operation capability analysis 278
(three) profitability analysis of enterprises 281
Two. Beijing Jing Wei Yuan Hua Pharmaceutical Technology Co., Ltd. 282
(1) analysis of debt paying ability of enterprises 282
(two) enterprise operation capability analysis 284
(three) profitability analysis of enterprises 287
Three. Liaoning Sheng Sheng pharmacy chain Co. Ltd. 289
(1) analysis of debt paying ability of enterprises 289
(two) enterprise operation capability analysis 291
(three) profitability analysis of enterprises 294
Four. Shanghai pharmacy chain Co. Ltd. 295
(1) analysis of debt paying ability of enterprises 296
(two) enterprise operation capability analysis 298
(three) profitability analysis of enterprises 301
The thirteenth chapter is Chinese medicine electronic commerce -- the analysis of the main operation of online pharmacies 303
Section 1 Hunan peoples medicine chain 303
1. Background analysis of business development 303
Two, business efficiency analysis 303
Three, business development status 304 本文章更多内容: 1 - 2 - 下一页>>

Market survey report on Chinas pharmaceutical e-commerce industry in 2018-2025 years
订购电话:010-57302178 010-57302159
绿色通道:13051511061 15600031156(24小时服务)

报告价值

  本报告由亚泰中研制作出版,是您全面深入了解该产业发展状况及投资机会的最佳参考工具。亚泰中研是中国领先产业研究与投资咨询机构,经过十多年时间的发展,亚泰中研已经构建了自有调查渠道包括网络、官方数据库、上市公司、调查公司、研究院、政府部门、行业协会、国外权威研究机构等在内的多渠道、多层面的数据来源;建立了包括国际国内上百个行业的千万级的数据库;形成了多种专业分析模型和研究方法;拥有近百名专业的行业分析师咨询师和业内专家。这些都是亚泰中研产品和服务专业性的有效保证。目前亚泰中研业务范围主要覆盖了细分产业研究、产业分析、市场现状、销售价格、前景展望、战略规划、未来预测、市场调查、市场调研、可行性分析与可行性研究等、商业计划书、营销策划、IPO咨询、专项市场解决方案、产业/园区规划、企业发展战略规划、数据库营销服务等以及为满足企业学习和提升经营能力的世界级经营管理智慧,我们已经成为一家多层次、多维度的综合性投资咨询机构。十多年来,亚泰中研已经为数万家包括政府机构、银行、研究所、行业协会、咨询公司、集团公司和各类投资公司在内的单位提供了专业咨询、信息咨询及研究报告、调查报告服务,并得到客户的广泛认可。

报告价值

· 该行业有多大市场规模?发展前景如何?值不值得投资?

· 市场细分和企业定位是否准确?主要客户群在哪里?营销手段有哪些?

· 您与竞争对手企业的差距在哪里?竞争对手的战略意图在哪里?

· 保持领先或者超越对手的战略和战术有哪些?会有哪些优劣势和挑战?

· 该行业的最新变化有哪些?市场有哪些新的发展机遇与投资机会?

· 该行业发展大趋势是什么?您应该如何把握大趋势并从中获得商业利润?

· 该行业内的成功案例、准入门槛、发展瓶颈、赢利模式、退出机制……

· 进入该行业需要了解哪些信息风险?原材料压力、政策和体制风险分析 ?

· 国内市前景预测,国际市前景预测、行业存在问题及对策解决?

数据支持

· 权威数据:国家统计局、国家信息中心、国家税务总局、国家工商总局、国务院发展研究中心、国家海关总署、全国商业信息中心、商务部研究院、清华大学图书馆、国家图书馆、全国200多个行业协会、行业研究所、海外产业研究机构等上万种专业信息来源。

· 亚泰中研自主研发数据库:亚泰中研细分行业数据库、亚泰中研上市公司数据库、亚泰中研非上市企业数据库、宏观经济数据库、区域经济数据库、产品产销数据库、产品进出口数据库。

· 最新一手数据:遍布全国32个省市业内专家顾问网络,涉及政府统计部门、统计机构、生产厂商、销售商、下游需求商、地方主管部门以及在华投资机构。在中国,亚泰中研咨询拥有最大的数据搜集网络数据库,在研究项目最多的一线城市设立了办事处,并在超过50多个城市建立了操作地,资料搜集的工作已覆盖200个地区。

研发流程

研发流程定制报告

· 步骤1:设立研究小组,确定研究内容

· 步骤2:市场总量调研

· 步骤3:市场占有率调查

· 步骤4:企业产销量上下游调查

· 步骤5:核实来自各方信息渠道的数据与基础资料整理

· 步骤6:进行数据建模分析研究并起草初步研究框架

· 步骤7:专家访谈、审阅并提出意见与建议

· 步骤8:分析师系统分析并撰写最终最新报告
(对行业盈利点、增长点、机会点、预测点等进行系统分析并完成报告)

· 步骤9:客户反馈跟进与售后服务
(对用户提出的有关问题给予免费解答;了解客户反馈,并就有关问题进行深入调查和项目咨询)

热点关注
图说
最新报告
今日推荐